Month: January 2024

Ayvens publishes the Purchase Price Allocation of LeasePlan

Written by Customer Service on January 10, 2024. Posted in Earnings Releases And Operating Results.

Ayvens progressed further in the integration of LeasePlan, which is proceeding according to plan. The allocation of LeasePlan’s purchase price to acquired assets and assumed liabilities as at the date of acquisition closing (22 May 2023)1 led Ayvens to revise upwards the value of LeasePlan’s net assets by c. EUR 230 million, as a result of the assessment of LeasePlan’s assets and liabilities at fair value2:Lease assets: c. EUR +380 million; Customer relationship: c. EUR +150 million3; Software: c. EUR -200 million; Other assets and liabilities: c. EUR -100 million. Subject to any final Purchase Price Allocation and/or acquisition price adjustment within one year from closing4, the goodwill recognized on the acquisition is reduced by c. EUR 220 million to c. EUR 1,390 million. This has a positive impact on the CET1 capital of c. EUR 220 million,...

Bang & Olufsen interim report for Q2 2023/24: Strong gross margin contributed to positive earnings in Q2 despite lower revenue

Written by Customer Service on January 10, 2024. Posted in Earnings Releases And Operating Results.

Bang & Olufsen improved its gross margin significantly by 9 percentage points in the second quarter of the financial year (September-November) and delivered positive earnings despite declining revenue compared to last year. Customer demand remained stable during the quarter with like-for-like sell-out growing by 2%. However, group revenue declined by 18.5%, (-16% in local currencies). Negative growth had been expected for Q2, especially due to the successful launch of the soundbar Beosound Theatre last year. Additionally, the company’s decision to exit several multibrand stores as part of its strategic transition had a revenue impact. The price increases announced for 1 September 2023 also pulled some revenue into Q1. Lastly, the slower-than-expected recovery of the Chinese economy adversely impacted sales. Gross margin increased...

Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands

Written by Customer Service on January 10, 2024. Posted in Mergers And Acquisitions.

Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands Saint-Cloud, 10 January 2024 – Elis, the global leader in circular services at work, today announces the signing of an agreement to acquire 100% of Moderna Holding BV (« Moderna ») in the Netherlands. The closing of the transaction is expected to occur before the end of Q1 2024, subject to the standard regulatory reviews. Moderna operates a very modern plant that will become one of the largest plants of the Group. The plant is located in the North-Eastern region of the country, close to the German border, and can address the entire Dutch territory thanks to 2 supply centers. Moderna employs around 400 people. It provides Flat linen, Workwear, and Hygiene & Well-being services to clients in the Hospitality, Industrial, and Trade...

IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market

Written by Customer Service on January 10, 2024. Posted in Mergers And Acquisitions.

Main image_IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market_Photographed from left to right:Ms. Rakhi Rediz, Director – Beauty and Personal Care, IMCD IndiaMr. Shailesh Karwa, Co-founder and Director, Valuetree IngredientsMr. Sharad Dalmia, Co- founder and Director, Valuetree IngredientsMr. Narendra Varde, Managing Director, IMCD India & BangladeshMs. Fenna van Zanten, IMCD Group Director Mergers & AcquisitionsMr. Ramanuj Kankani, Director – Finance & Operations, IMCD India & BangladeshROTTERDAM, The Netherlands (10 January 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces the acquisition...

SIKA POSTS RECORD SALES OF CHF 11.24 BILLION IN 2023 – GROWTH OF 7.1% IN CHF

Written by Customer Service on January 10, 2024. Posted in Public Companies.

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.24 BILLION IN 2023 – GROWTH OF 7.1% IN CHFSika posts record sales of CHF 11.24 billion in 2023 Revenue growth of +7.1% in CHF (+14.5% in local currencies) High, negative foreign currency effect of -7.4% due to sharp appreciation of the Swiss franc Integration of MBCC on track with expected synergies of CHF 180–200 million Acquisition of Thiessen Team (USA) and Chema (Peru) as well as a stake in start-up Concria Oy (Finland) New plants commissioned in Kharagpur (East India) and Chattanooga (Tennessee, USA) and expansion of two factories in Sealy (Texas, USA) and Kirchberg (Switzerland) Technology Center opened in Suzhou (China) Outlook for fiscal 2023 confirmed:Over-proportional increase in EBIT excluding MBCC acquisition Operating...

Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine

Written by Customer Service on January 10, 2024. Posted in Public Companies.

SHANGHAI, China, Jan. 09, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from TORCHLIGHT (NCT04085276), a randomized, double-blind, placebo-controlled phase 3 study comparing the efficacy and safety of toripalimab versus placebo, in combination with nab-paclitaxel for patients with newly diagnosed metastatic or recurrent locally advanced triple-negative breast cancer (TNBC) in Nature Medicine. TORCHLIGHT is the first registered Phase 3 study to achieve positive results in advanced TNBC immunotherapy in China. It was jointly conducted across 56 centers nationwide, with principal investigator Professor...

River Valley Community Bancorp Announces Director Retirement

Written by Customer Service on January 10, 2024. Posted in Public Companies.

YUBA CITY, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — River Valley Community Bancorp (OTC markets: RVCB) with its wholly owned subsidiary, River Valley Community Bank (collectively referred to as the “Bank”), today announced the retirement of director J. Terry Eager. Mr. Eager has served on the Bank’s Board since it was formed in June 2006. Mr. Eager is a CPA and retired partner with PricewaterhouseCoopers, LLP (PwC). In addition to his professional background, Mr. Eager has agricultural and business interests in Sutter and Yuba counties. His local roots and experience positioned him well for having an impactful role on the Bank’s Board. During his tenure, Mr. Eager actively served on the Audit and Asset Liability Committees, he was former Chair of the Audit Committee and Vice Chairman of the Board. Board Chair Stephen F. Danna...

Australian Independent Publisher IndieMosh Joins the Tellwell Publishing Family

Written by Customer Service on January 10, 2024. Posted in Mergers And Acquisitions.

VANCOUVER ISLAND, British Columbia, Jan. 09, 2024 (GLOBE NEWSWIRE) — In a landmark move, Tellwell Publishing proudly embraces IndieMosh as the latest addition to its book-publishing ventures. Tellwell is recognized internationally for its trustworthiness, transparency, and integrity in the self-publishing space. This aligned collaboration marks a new era for IndieMosh, now operating seamlessly as an imprint of Tellwell Publishing, as of November 2023. IndieMosh authors will now have access to an expanded suite of publishing services, including book coaching, ghostwriting, editing, design, distribution, and book marketing. IndieMosh authors will continue receiving the personalized guidance they are used to, along with the guidance and expertise of a more extensive team of talented publishing professionals. “This marks the beginning...

Vital Energy Provides Select Preliminary Fourth-Quarter 2023 Results

Written by Customer Service on January 9, 2024. Posted in Public Companies.

Total and oil production exceed outlook with capital investments in-line Company provides fourth-quarter and full-year 2023 earnings and conference call details TULSA, OK, Jan. 09, 2024 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) today provided select preliminary results for fourth-quarter 2023, including average daily total and oil production and incurred capital investments. Details for the Company’s fourth-quarter and full-year 2023 earnings release and conference call are provided within this release. Fourth-Quarter 2023 Preliminary Production and Capital Expenditures Production. The Company’s fourth-quarter 2023 total production averaged approximately 113.4 thousand barrels of oil equivalent per day (“MBOE/d”), above guidance of 101.8 – 105.8...

Guardian Capital Announces Revised Annual 2023 Special Distributions for Certain Guardian Capital ETFs

Written by Customer Service on January 9, 2024. Posted in Dividend Reports And Estimates.

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) — Guardian Capital LP (“Guardian Capital”) today announced a revision to the annual special year-end distributions (the “Special Distributions”) for the 2023 tax year for the ETF series of Guardian Directed Equity Path Portfolio (TSX: GDEP, GDEP.B), Guardian Canadian Bond Fund (TSX: GCBD) and Guardian Ultra-Short U.S. T-Bill Fund (TSX: GUTB.U) (the “Guardian Capital ETFs”). Please note that this is an update to the annual special year-end distributions for the Guardian Capital ETFs and supersede the amounts previously announced on December 29, 2023.Guardian Capital ETFs Series of ETF Units TSX Trading Symbol Revised Special Distribution Amount (per ETF Unit)Guardian Canadian Bond Fund ETF Units GCBD CAD$0.0078Guardian Directed Equity Path Portfolio Hedged...

Month: January 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals